FDA staff flags concerns about Capricor's Duchenne heart disease therapy - Reuters

FDA staff flags concerns about Capricor's Duchenne heart disease therapy Reuters

1 reportinternational

Claim audit

No BS check run yet — press ⚖ to extract this story's claims and verify them against independent sources.

All coverage